ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621335 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621335; 2) Community: the network communities that were significantly associated with the response to NSC 621335; 3) Molecule: the relationships between components within communities and NSC 621335; 4) MDR: the compounds that were significantly associated with the NSC 621335.

NSC Compound Enrichment Correlation
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.0133299224082802 -0.067081696
NSC 649270 Benzo[d]naphtho[1,2-b]pyran-6-one, 1-hydroxy-10-methyl-7,8,9,10-tetrahydro- 0.0133299224082802 -0.25909371
NSC 670283 2,2'-Spirobi[2H-benz[f]indene]-5,5'-dione, 1,1',3,3',5,5',6,6',7,7',8,8'-dodecahydro- 0.0133299224082802 0.27415463
NSC 670995 Null 0.0133299224082802 -0.049040744
NSC 674964 Spiro[s-indacene-2(1H),2'-[2H]indene]-8-carboxylic acid, 3,5,6,7,1',3'-hexahydro-3'-oxo- 0.0133299224082802 0.29890264
NSC 676443 Null 0.0133299224082802 0.20296889
NSC 678128 Null 0.0133299224082802 0.43706512
NSC 681640 Camptothecin Derivative 0.0133299224082802 -0.21395353
NSC 681642 Camptothecin Derivative 0.0133299224082802 -0.12102597
NSC 682096 Quinolinium, 4-amino-2-methyl-1-[10-[(2-methyl- 4-quinolinyl)amino]decyl]-, chloride, monohydrochloride 0.0133299224082802 0.47087109
Total:112  Current:39    [First] [Prev] [Next] [Last]